Anti-EBV gp350 [HB5] Antibody

This mouse IgG2a monoclonal antibody was raised against purified epstein-barr virus (EBV) and is specific for human EBV surface glycoprotein gp350.


  • Recognizes human EBV gp350
  • Works well for EBV neutralization
  • Suitable for Western Blot, ELISA, Flow Cytometry, EBV in vitro Neutralization and Epitope Mapping applications

Epstein-Barr virus (EBV) infection is the causal agent of acute infectious mononucleosis and is associated with numerous epithelial and lymphoid malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, Burkitt lymphoma, Hodgkin lymphoma, and post-transplant lymphoproliferative diseases (PTLD). EBV uses multiple surface glycoproteins (gps), including the major gp350, to infect host cells. EBV gp350 is a type 1 membrane protein that encodes for 907 amino acid (aa) residues and codes for a 350 kDa glycoprotein and a 220 kDa splice variant.

From the laboratory of Javier Gordon Ogembo, PhD, City of Hope.

Catalog Number Product DataSheet Size AVAILABILITY Price Qty
Anti-EBV gp350 [HB5] Antibody
100ug In stock
Regular Price:$328.00
On Sale:

Product Type: Antibody
Antigen: EBV gp350
Accession ID: P03200
Molecular Weight: 350/220 kDa
Isotype: IgG2a
Clonality: Monoclonal
Clone Name: HB5
Reactivity: Human
Immunogen: Purified EBV
Species Immunized: Mouse
Buffer: 0.1M Sodium Phosphate, pH 7.4, 0.15M NaCl, 0.05% (w/v) Sodium Azide
Tested Applications: WB 1:50 (Unpurified Hybridoma supernatant), ELISA (10µg/ml), Flow cytometry (10µg/ml), EBV in vitro Neutralization (10-50µg/ml), Epitope Mapping (10µg/ml)
Storage: -20C
Shipped: Cold Packs

From the laboratory of Javier Gordon Ogembo, PhD, City of Hope.

  1. Mutsvunguma LZ, Rodriguez E, Escalante GM, Muniraju M, Williams JC, Warden C, Qin H, Wang J, Wu X, Barasa A, Mulama DH, Mwangi W, Ogembo JG. Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes. Virology. 2019 Jul 30;536:1-15. doi: 10.1016/j.virol.2019.07.026. [Epub ahead of print] PubMed PMID: 31377598.

If you publish research with this product, please let us know so we can cite your paper.